Crazily Good Reasons Not To Buy Shares
A look at some of the more lateral reasons to avoid certain companies. Continue reading
These Shares Won’t Rise In 2012
Or will they? We hunt for value among the biggest fallers so far this year. Continue reading
Fund Managers Fight Back
Fund managers say they're 'worth it'. But is it true? Continue reading
Expert Stock Picks: Mid-Cap Prospects
We spotlight some of the best mid-cap ideas from top professional stockpickers. Continue reading
Next Month’s Blue Chip Buying Opportunities
February will be a busy month for watchers of big company results. Continue reading
My Free Research On A Quality Blue Chip
Down 10% last year, this large-cap now looks priced to deliver solid rewards. Continue reading
My Bet On The Global Generics Boom
A novel way to play the approaching pharma patent cliff. Continue reading
Now Might Be The Time To Buy This Fallen Star
Short-term trading issues at Invensys currently overshadow two attractive divisions. Continue reading
A Healthcare Alternative To Smith & Nephew
Across the pond, there's a medical devices company well worth taking a look at. Continue reading
HMV Price Doubles!
A new banking deal gives the struggling music dealer some breathing space. Continue reading
Advertisers